QR Code

Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow‐on formula manufactured from hydrolysed protein by Danone Trading ELN B.V.

Abstract The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from whey protein concentrate and used in an infant and follow‐on formula by Danone Trading ELN B.V, which submitted a dossier to the European...

Description complète

Enregistré dans:
Auteurs principaux: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), Jacqueline Castenmiller, Stefaan deHenauw, Karen‐Ildico Hirsch‐Ernst, John Kearney, Helle Katrine Knutsen, Alexandre Maciuk, Inge Mangelsdorf, Harry J McArdle, Androniki Naska, Carmen Pelaez, Kristina Pentieva, Alfonso Siani, Frank Thies, Sophia Tsabouri, Marco Vinceti, Jean‐Louis Bresson, Laurence Castle, Mary Fewtrell, Hildegard Przyrembel, Céline Dumas, Ariane Titz, Dominique Turck
Format: Artigo
Langue:Inglês
Publié: Wiley 2020-11-01
Collection:EFSA Journal
Sujets:
Protein hydrolysate
characterisation
formula
nutritional safety
suitability
clinical trial
Accès en ligne:https://doi.org/10.2903/j.efsa.2020.6304
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires